flow trial semaglutide kidney outcomes results 2024 in patients with overweight or obesity and chronic disease without diabetes: a randomized double-blind placebo-controlled clinical The rationale, design and baseline

Specific Populations Effects of Age, Gender, Race and Body Weight on Pharmacokinetics Based on a population pharmacokinetic analysis, age, gender, race, and body weight do not have a clinically meaningful effect on the pharmacokinetics of saxagliptin and dapagliflozin

Feb 19, 2026 On paper, they look like the same thing

Long-term efficacy and safety of once-weekly semaglutide for weight loss in patients without diabetes: a systematic review and meta-analysis of randomized controlled trials

Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population

Reduced Cravings: It acts on the brain's appetite centers, helping to diminish food cravings and hunger pangs